Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Pink, D; West, A; Andreou, D.
[Systemic Therapy Options for Locally Advanced and Metastatic Myxoid, Dedifferentiated and Pleomorphic Liposarcoma].
Zentralbl Chir. 2020; 145(2):160-167
Doi: 10.1055/a-1117-4143
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Andreou Dimosthenis
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Just a few years ago, all patients with metastatic soft tissue sarcoma received the same chemotherapy drugs. However, it is now recognised that the various sarcoma subtypes are different tumours with distinct genetic alterations and different biological behaviour, so that histology-specific treatment protocols have been increasingly implemented in recent years. This is also the case for the different subtypes of liposarcoma - the myxoid/round cell variant, as well as dedifferentiated and pleomorphic liposarcoma. This article will present published data and the authors' experience with the various systemic treatment options. both in first line and in subsequent lines of treatment, as well as a brief overview of experimental treatment approaches.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Liposarcoma - administration & dosage
-
Sarcoma - administration & dosage
-
Soft Tissue Neoplasms - administration & dosage
- Find related publications in this database (Keywords)
-
liposarcoma
-
chemotherapy
-
sarcoma
-
myxoid
-
dedifferentiated
-
pleomorphic